| pubmed-article:10217588 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10217588 | lifeskim:mentions | umls-concept:C1456594 | lld:lifeskim |
| pubmed-article:10217588 | lifeskim:mentions | umls-concept:C0205476 | lld:lifeskim |
| pubmed-article:10217588 | lifeskim:mentions | umls-concept:C0442118 | lld:lifeskim |
| pubmed-article:10217588 | lifeskim:mentions | umls-concept:C0021403 | lld:lifeskim |
| pubmed-article:10217588 | lifeskim:mentions | umls-concept:C0332161 | lld:lifeskim |
| pubmed-article:10217588 | lifeskim:mentions | umls-concept:C0036043 | lld:lifeskim |
| pubmed-article:10217588 | lifeskim:mentions | umls-concept:C0332287 | lld:lifeskim |
| pubmed-article:10217588 | lifeskim:mentions | umls-concept:C1518896 | lld:lifeskim |
| pubmed-article:10217588 | lifeskim:mentions | umls-concept:C1521801 | lld:lifeskim |
| pubmed-article:10217588 | lifeskim:mentions | umls-concept:C0205191 | lld:lifeskim |
| pubmed-article:10217588 | lifeskim:mentions | umls-concept:C1548795 | lld:lifeskim |
| pubmed-article:10217588 | lifeskim:mentions | umls-concept:C0348080 | lld:lifeskim |
| pubmed-article:10217588 | lifeskim:mentions | umls-concept:C1311943 | lld:lifeskim |
| pubmed-article:10217588 | pubmed:issue | 15-16 | lld:pubmed |
| pubmed-article:10217588 | pubmed:dateCreated | 1999-7-8 | lld:pubmed |
| pubmed-article:10217588 | pubmed:abstractText | We conducted a randomized, double-blind trial to evaluate the safety and tolerability of a live attenuated cold adapted trivalent intranasal influenza vaccine, FluMist, compared with intranasal placebo when given in addition to a licensed trivalent injected inactivated influenza vaccine (TIV). The study population consisted of persons 65 years of age and older with chronic cardiovascular or pulmonary conditions or diabetes mellitus. During the 7 days post-vaccination, sore throat was reported on at least one day by 15% (15/100) of FluMist recipients compared with 2% (2/100) of intranasal placebo recipients (p = 0.001). No other reactogenicity symptom was statistically associated with receipt of FluMist. Among this group, FluMist was safe and well tolerated when administered with TIV. | lld:pubmed |
| pubmed-article:10217588 | pubmed:language | eng | lld:pubmed |
| pubmed-article:10217588 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10217588 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:10217588 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10217588 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10217588 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10217588 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10217588 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:10217588 | pubmed:issn | 0264-410X | lld:pubmed |
| pubmed-article:10217588 | pubmed:author | pubmed-author:ChuSS | lld:pubmed |
| pubmed-article:10217588 | pubmed:author | pubmed-author:HolmesS JSJ | lld:pubmed |
| pubmed-article:10217588 | pubmed:author | pubmed-author:MendelmanP... | lld:pubmed |
| pubmed-article:10217588 | pubmed:author | pubmed-author:JacksonL ALA | lld:pubmed |
| pubmed-article:10217588 | pubmed:author | pubmed-author:HugginsLL | lld:pubmed |
| pubmed-article:10217588 | pubmed:author | pubmed-author:RhorerJJ | lld:pubmed |
| pubmed-article:10217588 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10217588 | pubmed:day | 9 | lld:pubmed |
| pubmed-article:10217588 | pubmed:volume | 17 | lld:pubmed |
| pubmed-article:10217588 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10217588 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10217588 | pubmed:pagination | 1905-9 | lld:pubmed |
| pubmed-article:10217588 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:10217588 | pubmed:meshHeading | pubmed-meshheading:10217588... | lld:pubmed |
| pubmed-article:10217588 | pubmed:meshHeading | pubmed-meshheading:10217588... | lld:pubmed |
| pubmed-article:10217588 | pubmed:meshHeading | pubmed-meshheading:10217588... | lld:pubmed |
| pubmed-article:10217588 | pubmed:meshHeading | pubmed-meshheading:10217588... | lld:pubmed |
| pubmed-article:10217588 | pubmed:meshHeading | pubmed-meshheading:10217588... | lld:pubmed |
| pubmed-article:10217588 | pubmed:meshHeading | pubmed-meshheading:10217588... | lld:pubmed |
| pubmed-article:10217588 | pubmed:meshHeading | pubmed-meshheading:10217588... | lld:pubmed |
| pubmed-article:10217588 | pubmed:meshHeading | pubmed-meshheading:10217588... | lld:pubmed |
| pubmed-article:10217588 | pubmed:meshHeading | pubmed-meshheading:10217588... | lld:pubmed |
| pubmed-article:10217588 | pubmed:meshHeading | pubmed-meshheading:10217588... | lld:pubmed |
| pubmed-article:10217588 | pubmed:meshHeading | pubmed-meshheading:10217588... | lld:pubmed |
| pubmed-article:10217588 | pubmed:meshHeading | pubmed-meshheading:10217588... | lld:pubmed |
| pubmed-article:10217588 | pubmed:meshHeading | pubmed-meshheading:10217588... | lld:pubmed |
| pubmed-article:10217588 | pubmed:meshHeading | pubmed-meshheading:10217588... | lld:pubmed |
| pubmed-article:10217588 | pubmed:meshHeading | pubmed-meshheading:10217588... | lld:pubmed |
| pubmed-article:10217588 | pubmed:meshHeading | pubmed-meshheading:10217588... | lld:pubmed |
| pubmed-article:10217588 | pubmed:meshHeading | pubmed-meshheading:10217588... | lld:pubmed |
| pubmed-article:10217588 | pubmed:meshHeading | pubmed-meshheading:10217588... | lld:pubmed |
| pubmed-article:10217588 | pubmed:meshHeading | pubmed-meshheading:10217588... | lld:pubmed |
| pubmed-article:10217588 | pubmed:year | 1999 | lld:pubmed |
| pubmed-article:10217588 | pubmed:articleTitle | Safety of a trivalent live attenuated intranasal influenza vaccine, FluMist, administered in addition to parenteral trivalent inactivated influenza vaccine to seniors with chronic medical conditions. | lld:pubmed |
| pubmed-article:10217588 | pubmed:affiliation | Immunization Studies Program, Center for Health Studies, Group Health Cooperative of Puget Sound, WA, USA. lajack@u.washington.edu | lld:pubmed |
| pubmed-article:10217588 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:10217588 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:10217588 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10217588 | lld:pubmed |
